Stock Financial Ratios


CBIO / Catalyst Biosciences Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price10.49
Volume376,800.00
Market Cap ($M)38.41
Enterprise Value ($M)-28.45
Book Value ($M)16.07
Book Value / Share20.63
Price / Book1.72
NCAV ($M)16.12
NCAV / Share20.70
Price / NCAV1.84
Income Statement (mra) ($M)
Revenue0.00
EBITDA-20.42
Net Income-16.95
Balance Sheet (mrq) ($M)
Cash & Equivalents10.97
Cash / Share14.08
Assets34.39
Liabilities9.51
Quick Ratio1.71
Current Ratio1.71
Management Effectiveness (mra)
Return on Invested Capital (ROIC)-1.05
Return on Assets (ROA)-0.44
Return on Equity (ROE)-1.05
Identifiers and Descriptors
CUSIP14888D109
Central Index Key (CIK)1124105
Industry Groups
SIC 2834 - Pharmaceutical Preparations
Other Related CUSIPS
14888D909
14888D958
14888D959
14888D208
Share Statistics
Common Shares Outstanding (M)4.31
Scoring Models
Piotroski F Score2.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Kaplan-Zingales KZ-IndexN/A
Cash Conversion CycleN/A
Per Share Metrics
Accounts Receivable Per Share0.00
Property Plant And Equipment Per Share0.40
Inventory Raw Materials Per Share0.00
Cash Per Share14.08
Assets Other Current Per Share0.00
Inventory Finished Goods Per Share0.00
Liabilities Other Non Current Per Share0.00
Preferred Stock Value Outstanding Per Share0.00
Assets Current Per Share43.74
Assets Non Current Per Share0.00
Accumulated Depreciation And Depletion Per Share0.00
Cash And Equivalents Per Share14.08
Additional Paid In Capital Per Share247.21
Minority Interest Per Share0.00
Liabilities Per Share12.21
Assets Per Share44.14
Inventory Work In Progress Per Share0.00
Long Term Debt Per Share0.00
Treasury Stock Per Share0.00
Accounts Payable Per Share0.00
Debt Per Share0.00
Inventory Per Share0.00
Equity Per Share31.93
Assets Other Non Current Per Share0.00
Retained Earnings Per Share-215.28
Intangibles Per Share0.00
Liabilities And Stock Equity Per Share44.14
Goodwill Per Share0.00
Property Plant And Equipment Net Per Share0.40
Liabilities Current Per Share12.21
Deferred Income Tax Liabilities Per Share0.00
Current Portion Of Long Term Debt Per Share0.00
Property Plant And Equipment Gross Per Share0.00

Related News Stories

BRIEF-Financial milestone achieved in Catalyst's subcutaneous factor IX program

2017-07-06 reuters
* Catalyst Biosciences Inc - ISU ABXIS and Catalyst plan to have top-line data from clinical trial by end of 2017 for CB 2679d/ISU304 Source text for Eikon: Further company coverage:

BRIEF-Catalyst Biosciences' Factor IX granted orphan drug designation in Europe

2017-06-28 reuters
* Catalyst Biosciences - European Commission granted orphan medicinal product designation to CB 2679d/ISU304, clinical stage drug candidate for hemophilia B Source text for Eikon: Further company coverage:

CUSIP: 14888D109